These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4669960)

  • 1. Hypophysectomy for metastatic cancer.
    Ray BS
    J Med Liban; 1972; 25(5):393-400. PubMed ID: 4669960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypophysectomy in the treatment of disseminated carcinoma of the breast and prostate gland.
    Tindall GT; Ambrose SS; Christy JH; Patton JM
    South Med J; 1976 May; 69(5):579-83. PubMed ID: 1273614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of breast cancer with antiestrogen: approach to medical hypophysectomy?
    Manni A; Trujillo J; Brodkey J; Marshall JS; Pearson OH
    Trans Assoc Am Physicians; 1977; 90():342-52. PubMed ID: 611666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transsphenoidal hypophysectomy in the treatment of metastatic breast and prostate carcinoma.
    Silverberg GD; Britt RH
    West J Med; 1979 Mar; 130(3):191-5. PubMed ID: 425500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogen treatment of breast cancer: an overview.
    Pearson OH; Manni A; Arafah BM
    Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of total removal or subtotal removal combined gamma knife radiation on giant pituitary adenoma: a report of 160 cases].
    Xiao QH; Huang SQ; Mao BY; Li GP; Ju Y
    Ai Zheng; 2007 Jul; 26(7):742-7. PubMed ID: 17626751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrinologically incomplete transethmoidal trans-sphenoidal hypophysectomy with relief of bone pain in breast cancer.
    LaRossa JT; Strong MS; Melby JC
    N Engl J Med; 1978 Jun; 298(24):1332-5. PubMed ID: 651992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
    Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
    Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
    Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
    Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of serum prolactin determination in metastatic breast cancer patients.
    Mujagić Z; Mujagić H
    Croat Med J; 2004 Apr; 45(2):176-80. PubMed ID: 15103755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial.
    Nicolini A; Carpi A
    Biomed Pharmacother; 2005 Jun; 59(5):253-63. PubMed ID: 15913946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of women with metastatic breast cancer: a descriptive study according to age group.
    Manders K; van de Poll-Franse LV; Creemers GJ; Vreugdenhil G; van der Sangen MJ; Nieuwenhuijzen GA; Roumen RM; Voogd AC
    BMC Cancer; 2006 Jul; 6():179. PubMed ID: 16824210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.